Inventiva Lanifibranor MASLD MASH Vascular Alterations 2024

Inventiva's LEGEND presentation discusses vascular pathophysiology in metabolic dysfunction-associated liver disease (MASLD/MASH), examining how structural and functional vascular changes contribute to portal hypertension. The presentation covers pre-clinical and human data on lanifibranor's effects, presented by hepatology expert Sven M.A. Francque from Antwerp University Hospital.